clotrimazole and cyclin d1

clotrimazole has been researched along with cyclin d1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horrobin, DF1
Lau, CP; Li, GR; Tao, R; Tse, HF1
Aktas, BH; Grubissich, L; Halperin, JA; Harbinski, F; Ozdelen, E; Qiao, Y; Schubert, R; Sevinc, S; Singer, S1

Other Studies

3 other study(ies) available for clotrimazole and cyclin d1

ArticleYear
A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels.
    Medical hypotheses, 2003, Volume: 60, Issue:5

    Topics: Angiogenesis Inhibitors; Cell Cycle; Clotrimazole; Cyclin D1; Cyclooxygenase Inhibitors; Eicosapentaenoic Acid; Humans; Lymphoma, Mantle-Cell; Protein Biosynthesis; Thalidomide

2003
Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.
    American journal of physiology. Cell physiology, 2008, Volume: 295, Issue:5

    Topics: Animals; Cell Cycle; Cell Proliferation; Cell Size; Cells, Cultured; Chloride Channels; Clotrimazole; Cyclin D1; Cyclin E; Dose-Response Relationship, Drug; Intermediate-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Nitrobenzoates; Potassium Channel Blockers; RNA Interference; RNA, Small Interfering

2008
Small-Molecule targeting of translation initiation for cancer therapy.
    Oncotarget, 2013, Volume: 4, Issue:10

    Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chromans; Clotrimazole; Cyclin D1; Disease Models, Animal; Eicosapentaenoic Acid; Eukaryotic Initiation Factor-2; Female; Humans; Mice; Mice, Inbred DBA; Peptide Chain Initiation, Translational; Phosphorylation; Protein Biosynthesis; Random Allocation; Thiazolidinediones; Troglitazone; Xenograft Model Antitumor Assays

2013